NOS3 and hypertensive disorder: For example, polymorphisms in the eNOS (NOS3) promoter have been found to alter the affinity of ETS family transcription factor binding, resulting in different levels of eNOS protein and functionality that can impact the development of hypertension (Salvi et al. 2013).